Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Precipio, Inc. is a healthcare biotechnology company specializing in cancer diagnostics. It develops and commercializes proprietary technologies and products, such as genetic panels and cell culture media, to improve diagnostic accuracy and reduce misdiagnoses in blood-related cancers. Operating CLIA-certified labs, it serves the U.S. oncology market with innovative, cost-effective solutions aimed at enhancing patient outcomes and laboratory efficiency.
This description was generated via AI from an annual report. Updated about 1 year ago.